
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DISP2 CRISPR/Cas9 KO Plasmid (m) | sc-431923 | 20 µg | $397.00 |
Dispatched RND transporter family member 2 (DISP2), encoded by the mouse Disp2 gene, is a multipass membrane protein related to the Dispatched family implicated in the release and extracellular distribution of lipid-modified Hedgehog ligands. Through modulation of Hedgehog morphogen availability, DISP2 is positioned to influence developmental patterning programs, epithelial–mesenchymal signaling, and tissue homeostasis governed by Hedgehog pathway activity. Altered Hedgehog signaling dynamics are relevant to studies of congenital developmental abnormalities and cancer-associated signaling reprogramming, making Disp2 a useful entry point for dissecting pathway regulation. In mouse models, Disp2 perturbation can be leveraged to investigate how membrane transport processes shape paracrine signaling gradients and downstream transcriptional outputs.
DISP2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Disp2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Disp2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Disp2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish DISP2 protein expression.
This CRISPR knockout system enables efficient generation of Disp2-deficient cell models for investigation of DISP2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.